Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$74.1K Sell
6,791
-135
-2% -$1.51K 0.04% 286
2022
Q1
$78.1K Buy
6,926
+1,280
+23% +$14.7K 0.02% 507
2021
Q4
$70.9K Buy
5,646
+5,170
+1,086% +$65.8K 0.02% 470
2021
Q3
$5.9K Hold
476
﹤0.01% 726
2021
Q2
$6.33K Hold
476
﹤0.01% 761
2021
Q1
$6.36K Sell
476
-918
-66% -$11.4K ﹤0.01% 612
2020
Q4
$13.6K Sell
1,394
-241
-15% -$2.38K ﹤0.01% 518
2020
Q3
$16.5K Hold
1,635
﹤0.01% 450
2020
Q2
$16.4K Sell
1,635
-7,031
-81% -$70.3K ﹤0.01% 402
2020
Q1
$82K Sell
8,666
-263,963
-97% -$3.3M 0.02% 304
2019
Q4
$3.56M Buy
272,629
+268,647
+6,747% +$3.6M 0.66% 44
2019
Q3
$49.7K Buy
3,982
+139
+4% +$1.65K 0.01% 369
2019
Q2
$45.2K Sell
3,843
-213
-5% -$2.4K 0.01% 396
2019
Q1
$48.6K Buy
4,056
+291
+8% +$4.04K 0.01% 342
2018
Q4
$57K Hold
3,765
0.01% 357
2018
Q3
$79.8K Sell
3,765
-2,017
-35% -$42.2K 0.02% 341
2018
Q2
$108K Sell
5,782
-12,168
-68% -$221K 0.02% 324
2018
Q1
$292K Sell
17,950
-3,173
-15% -$55K 0.06% 205
2017
Q4
$352K Buy
21,123
+7,042
+50% +$119K 0.06% 200
2017
Q3
$266K Buy
14,081
+7,436
+112% +$157K 0.05% 185
2017
Q2
$159K Buy
6,645
+1,436
+28% +$36.1K 0.03% 218
2017
Q1
$123K Buy
5,209
+1,194
+30% +$29.1K 0.03% 216
2016
Q4
$95.5K Sell
4,015
-459
-10% -$11.7K 0.02% 256
2016
Q3
$123K Buy
+4,474
New +$131K 0.02% 230
2016
Q2
Sell
-3,240
Closed -$104K 597
2016
Q1
$104K Sell
3,240
-1,487
-31% -$41.7K 0.01% 238
2015
Q4
$119K Buy
4,727
+630
+15% +$16.9K 0.02% 189
2015
Q3
$103K Buy
4,097
+185
+5% +$5.12K 0.01% 227
2015
Q2
$115K Hold
3,912
0.01% 245
2015
Q1
$135K Buy
3,912
+847
+28% +$31.6K 0.01% 248
2014
Q4
$121K Buy
+3,065
New +$123K 0.02% 266

Other funds holding LUMN

Exane Derivatives's LUMN Position: Q2 2022 in Review

Exane Derivatives reduced its Lumen (LUMN) stake by 1.9% in Q2 2022, selling an estimated $1.51K and leaving 6,791 shares worth $74.1K. The position accounts for 0.04% of the portfolio, ranked #286.

Exane Derivatives first reported a position in LUMN in Q4 2014 and has held it in 30 quarters since. The position peaked at $3.56M in Q4 2019. 806 funds tracked by Wall St. Rank hold LUMN as of Q2 2022.

  • Exane Derivatives held 6,791 shares of Lumen worth $74.1K as of Q2 2022.
  • Exane Derivatives sold 135 Lumen shares in Q2 2022, an estimated $1.51K.
  • Lumen made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #286 holding.
  • Exane Derivatives first reported a position in Lumen in Q4 2014 and has held it in 30 quarters since.
  • Exane Derivatives's Lumen position peaked at $3.56M in Q4 2019.
  • 806 funds tracked by Wall St. Rank held Lumen as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.